A summary of important health news from the past week.
The Food and Drug Administration (FDA) has ordered Juno Therapeutics to stop clinical trial for patients with relapsed or refractory B cell acute lymphoblastic leukemia after two patients died from cerebral edemas, or brain swelling. The trials were testing the effectiveness of immunotherapy, which harnesses the body's immune system. The research was in Phase II, which occurs after the initial phase that test the side effects and safety of new drugs.
A new report published on July 5th in the Journal of the American Medical Association shows that, in states with legalized physician assisted suicide, its use remains rare. The study finds that the main motivators for requesting physician assisted suicided are fear of losing autonomy and other psychological concerns rather than pain.
Clinton backs public option on health care in nod to Sanders supporters
Presumptive Democratic candidate Hillary Clinton expressed support for "public-options" for states, a position defended by Bernie Sanders. This provision expands tax-payer funded health insurance coverage beyond that of the Affordable Care Act. She also argued for allowing individuals to enroll in Medicare at 55 rather than 65.
House Passes Mental Health Bill
After a 422-2 vote, the House passed a bill that would provide more funding for mental illness treatment and redesign national mental health policy. The bill was designed in response to recent mass shootings in the U.S. In the bill, grants for treatment centers are refunded and it is now required that the head of the Substance Abuse and Mental Health Services Administration have a clinical background.
Who We Are
The Center is the hub of the science of human health for students, faculty, and staff at Emory University.